Opaganib is a “new chemical entity” administered orally to patients with Covid-19 and it performs “anticancer, anti-viral and anti-inflammatory activities.” The experimental drug from the Israeli biopharmaceutical RedHill Biopharma Ltd. was administered to patients in Israel for the first this month. Local media The Jerusalem Post reported that the first two patients who were treated … Continue reading Israeli drug ‘Opaganib’ successful in treating patients with COVID-19